NASDAQ:SVRA

Savara Stock Predictions

Healthcare > Biotechnology

Buy SVRA

*Your capital is at risk

$5.25

+0 (+0%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

SVRA Prediction Chart

SVRA Predictions History

Latest community submissions for SVRA.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
GoldenNugget Pro	May 6, 2019	$10.92 -1.84%	$11.12	X	98.16%	0
NameNotImportant Pro	Apr 24, 2019	$9.53 -7.66%	$10.32	X	92.35%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SVRA with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT SAVARA INC

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas....

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by